ArticleInfluenza and other respiratory viruses2026
Molecular Characterization of Human Adenoviruses Before and After a Severe HAdV-7 Military Outbreak in Finland in 2024.
Article in Influenza and other respiratory viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2024, a severe outbreak caused by human adenovirus type 7d (HAdV-7) occurred in Finnish military garrisons. Molecular typing was implemented to support outbreak control. The aim of this study was to determine adenovirus types circulating in Finnish garrisons during 2013-2023 by retrospective surveillance and to review earlier findings to better understand factors contributing to the 2024 outbreak.
methodsAdenovirus-positive respiratory samples collected through routine surveillance (2013-2023) and enhanced surveillance (2024-2025) were typed using type-specific PCR assays targeting types 3, 4, 7, 11, 14, 16, and 21. Whole-genome sequencing was performed on 11 selected samples. Index case interviews were conducted among conscripts infected with HAdV-7 in late 2023.
resultsDuring 2013-2023, among 497 typed samples, HAdV-4 was most common (n = 446; 89.7%), followed by HAdV-3 (n = 25; 5%). Other types detected were HAdV-21 (n = 11; 2.2%), HAdV-7 (n = 6; 1.2%), and HAdV-11 (n = 1; 0.2%). HAdV-4 was predominant in 2013-2017 and HAdV-3 in 2018-2019. Between February 2024 and June 2025, 1692 adenovirus-positive respiratory samples were typed. The adenovirus types detected were HAdV-4 (n = 1133; 67%), HAdV-7 (n = 440; 26%), co-detection of HAdV-4 and -7 (n = 70; 4.1%), and HAdV-14 (n = 1; 0.1%). Epidemiological investigation and whole-genome sequencing data revealed that the adenovirus associated with the 2024 outbreak (HAdV-7d) was already circulating in Finnish garrisons in 2023.
conclusionThe severity of the 2024 outbreak may reflect limited prior circulation of HAdV-7 in Finland. Although HAdV-7 continued to circulate among conscripts in 2025, the severity of the epidemic subsided, possibly due to effective preventative measures guided by active surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.